Inventor · disambiguated record
Hassan Lemjabbar-Alaoui
Also filed as: LEMJABBAR-ALAOUI HASSAN
8 granted patents·1 pending application·45 citations·filing 2006–2021
83Inventor score
Top patents by PatentIndex Score
9 records- 0192US7405227B2Treatment of cancerBIPAR SCIENCES INC·Filed 2006·Granted Jul 29, 2008·35 cites·8 claims
- 0283US11072600B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2017·Granted Jul 27, 2021·2 cites·42 claims
- 0383US10562886B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2016·Granted Feb 18, 2020·2 cites·39 claims
- 0482US11149025B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2020·Granted Oct 19, 2021·1 cites·18 claims
- 0582US8377985B2Treatment of cancerBIPAR SCIENCES INC·Filed 2008·Granted Feb 19, 2013·5 cites·9 claims
- 0674US11708352B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2021·Granted Jul 25, 2023·0 cites·19 claims
- 0772US12145925B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2021·Granted Nov 19, 2024·0 cites·33 claims
- 0870US10640493B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2019·Granted May 5, 2020·0 cites·4 claims
- 0952US2013331457A1Treatment of cancerBIPAR SCIENCES INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hassan Lemjabbar-Alaoui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →